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Abstract
Human genome-wide association studies have linked single nucleotide polymorphisms (SNPs) on chromosome 9p21.3 near
the INK4/ARF (CDKN2a/b) locus with susceptibility to atherosclerotic vascular disease (ASVD). Although this locus encodes
three well-characterized tumor suppressors, p16
INK4a, p15
INK4b, and ARF, the SNPs most strongly associated with ASVD are
,120 kb from the nearest coding gene within a long non-coding RNA (ncRNA) known as ANRIL (CDKN2BAS). While
individuals homozygous for the atherosclerotic risk allele show decreased expression of ANRIL and the coding INK4/ARF
transcripts, the mechanism by which such distant genetic variants influence INK4/ARF expression is unknown. Here, using
rapid amplification of cDNA ends (RACE) and analysis of next-generation RNA sequencing datasets, we determined the
structure and abundance of multiple ANRIL species. Each of these species was present at very low copy numbers in primary
and cultured cells; however, only the expression of ANRIL isoforms containing exons proximal to the INK4/ARF locus
correlated with the ASVD risk alleles. Surprisingly, RACE also identified transcripts containing non-colinear ANRIL exonic
sequences, whose expression also correlated with genotype and INK4/ARF expression. These non-polyadenylated RNAs
resisted RNAse R digestion and could be PCR amplified using outward-facing primers, suggesting they represent circular
RNA structures that could arise from by-products of mRNA splicing. Next-generation DNA sequencing and splice prediction
algorithms identified polymorphisms within the ASVD risk interval that may regulate ANRIL splicing and circular ANRIL
(cANRIL) production. These results identify novel circular RNA products emanating from the ANRIL locus and suggest causal
variants at 9p21.3 regulate INK4/ARF expression and ASVD risk by modulating ANRIL expression and/or structure.
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Introduction
Atherosclerotic vascular disease (ASVD) is a leading cause of
human mortality worldwide [1]. While there are well-recognized
risk factors for ASVD such as tobacco use, obesity and
hyperlipidemia, the identification of common genetic variants
associated with the disease has proven difficult despite strong
evidence that susceptibility is heritable. Recently, multiple
unbiased genome-wide wide association studies (GWAS) have
linked single nucleotide polymorphisms (SNPs) on chromosome
9p21 to ASVD and other related conditions (i.e. coronary artery
disease, stroke, myocardial infarction and aortic aneurysm) [2–12].
These associations have been replicated in multiple independent
studies and are not associated with ‘‘classical’’ ASVD risk factors
such as hypertension, obesity, tobacco use or lipid levels. While
causal variants within 9p21.3 have yet to be identified, the risk
associated SNPs cluster together within a 53 kb region roughly
100 kb centromeric to the INK4/ARF (CDKN2a/b) tumor
suppressor locus ([13] and Figure S1). Congenic mapping using
mice differentially susceptible to ASVD has identified syntenic
susceptibility alleles near the murine Ink4/Arf locus [14],
suggesting that this risk interval is conserved in mammals.
The INK4/ARF locus encodes three archetypal tumor suppres-
sor genes: p16
INK4a, p15
INK4b and ARF (p14
ARF in humans, p19
ARF
in mice), as well as a long non-coding RNA called Antisense Non-
coding RNA in the INK4 Locus (ANRIL or CDKN2BAS). Other
than a role for ARF in development of the optic vasculature, all of
the INK4/ARF proteins are thought to be largely dispensable for
normal mammalian development, but play important roles in
restraining aberrant proliferation associated with cancer and other
disease states (reviewed in: [15]). In purified T-cells from healthy
individuals, we have shown a pronounced effect of ASVD-
associated SNPs at 9p21 on INK4/ARF expression, with those
harboring the risk alleles demonstrating reduced levels of p15
INK4b,
p16
INK4a, ARF and ANRIL [16]. Decreased expression of such anti-
proliferative molecules could promote pathologic monocytic or
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(reviewed in [17,18]). For example, mice lacking p16
INK4a exhibit
increased vascular hyperplasia following intra-arterial injury [19]
and ARF deficiency has been implicated in atherosclerotic plaque
formation [20]. Additionally, TGF-b signaling, which induces the
expression of p16
INK4a and p15
INK4b, is anti-atherogenic in some
settings [21–23]. Most recently, excess proliferation of hemato-
poietic progenitor cells, which is in part controlled by p16
INK4a
expression during aging [24], has been associated with athero-
sclerosis in a murine model [25]. Moreover, targeted deletion of a
region syntenic to the ASVD risk interval in mice resulted in
severely attenuated expression of p15
INK4b and p16
INK4a [26].
Although these results suggest that the ASVD-associated 9p21
SNPs control INK4/ARF expression, and that decreased expres-
sion of the INK4/ARF tumor suppressors may promote ASVD, it is
not known how polymorphisms located ,120 kb away from the
locus might influence INK4/ARF expression.
ANRIL was first uncovered in a genetic analysis of familial
melanoma patients with neural system tumors [27]. Based upon
EST assembly, ANRIL has 19 exons with no identified open
reading frame [27] (Figure S2). Although cloning a full-length
version of the predicted transcript has proven difficult, a growing
number of alternatively spliced ANRIL transcripts have recently
been reported in the literature [28,29]. Many of these reports
suggest that multiple ANRIL isoforms can be expressed in a single
cell type. For example, two ANRIL variants have been reported in
testes, five in HUVECs and three in lung [27,28]. Further
confounding the study of ANRIL, the majority of predicted exons
are ,100 nucleotides in length and many consist entirely of
repetitive LINE, SINE and Alu elements (i.e. exons 7, 8, 12, 14 and
16) [30]. Without a firm understanding of ANRIL structure,
deciphering the biological function of this non-coding RNA has
become increasingly complicated.
More than a decade ago, elegant genetic work by Van
Lohuizen, DePinho and colleagues demonstrated that the Ink4/
Arf locus is potently repressed by Polycolmb group (PcG)
complexes [31]. Such repression appears critical for the persistence
and proliferation of somatic stem cells and other self-renewing
tissues such as pancreatic beta-cells [32,33]. Until recently little
progress was made in understanding the biochemical basis for
PcG-mediated INK4/ARF silencing, however two independent
groups have since shown that the PcG complexes, PRC-1 and
PRC-2, localize to the INK4/ARF locus and repress its activity
through the establishment of repressive chromatin modifications
such as H3K27 trimethylation [34–36]. Prior work has also shown
that long, non-coding RNAs such as Xist, Kcnq1ot1 and HOTAIR
can repress genes in cis- or trans- through interaction with PcG
complexes [37–40]. Moreover, dysregulation of HOTAIR has been
recently implicated in breast cancer progression, suggesting that
long, non-coding RNAs play an important role in human disease
[41]. Based on this evidence, we and others postulated that ANRIL
could play a similar role in PcG-mediated repression of the INK4/
ARF locus [16].
Against this background of prior work, we sought to better
determine ANRIL structure and expression in relation to ASVD-
SNP genotype and INK4/ARF expression. Toward that end, we
performed comprehensive DNA and RNA analyses of ANRIL
using RACE and next-generation sequencing in primary and
transformed cell lines. We showed that the expression of ANRIL
isoforms containing exons 1–2 or 4–6 correlated with ASVD-SNP
genotype, however those containing exons 18–19 did not.
Surprisingly, we also uncovered circular ANRIL (cANRIL) RNA
species whose expression correlated with ASVD-SNP genotype.
These new data suggest that the causal variant(s) within 9p21
influence ASVD susceptibility through regulation of ANRIL
expression and splicing, leading to differential PcG recruitment
and INK4/ARF repression.
Results
ANRIL transcription produces multiple rare, non-coding
RNA species
Multiple ANRIL isoforms have been proposed based upon the
assembly of ESTs and the sequencing of cDNA libraries (See
Figure S2). To determine which of these isoforms predominates in
vivo, we performed RNA ligase mediated (RLM)-RACE in cell
lines and primary human peripheral blood T-lymphocytes (PBTL).
In addition to using the RLM procedure to maximize the
detection of mRNA transcripts, we employed a high-fidelity Taq
polymerase capable of amplifying complex DNAs such as those
containing SINE, LINE and Alu elements. Primers for 39 and 59
RACE were designed within exons 1, 2, 4, 6, 9, 13, 16 and 18 of
the originally reported transcript, NR_003529 [27], but only
primers in exons 4 and 6 selectively amplified ANRIL sequences
(data not shown). These amplicons were cloned and sequenced to
verify the resulting DNA sequences. Using exon 4 and 6 primers,
we identified multiple ANRIL variants, including novel splice
isoforms that were not previously reported (Figure 1A, novel exons
shown in blue). We also detected several transcripts with a
peculiar, non-colinear exon sequence, most notably in the HeLa
and primary PBTL populations (shown in red in Figure 1A). Given
that no particular ANRIL isoform appeared to predominate from
our RACE data, we exploited the observation that ANRIL RNAs
containing exon 15 frequently maintained the canonical exonic
structure (e.g. 15–16–17–18–19). We termed these exons as
‘‘distal’’ because they are located at the 39 end of ANRIL, and
those prior to exon 15 as ‘‘proximal’’.
To examine the absolute abundance of transcripts containing
the ‘‘proximal’’ or ‘‘distal’’ exons in a variety of cell types, we
developed and validated quantitative Taqman primer-probe sets
spanning ANRIL exons 1–2, 4–6 and 18–19 (See Materials and
Author Summary
Unbiased studies of the human genome have identified
strong genetic determinants of atherosclerotic vascular
disease (ASVD) on chromosome 9p21.3. This region of the
genome does not encode genes previously linked to ASVD,
but does contain the INK4/ARF tumor suppressor locus.
Products of the INK4/ARF locus regulate cell division, a
process thought to be important in ASVD pathology. We
and others have suggested that genetic variants in 9p21.3
influence INK4/ARF gene expression; however, the mecha-
nisms by which these distant polymorphisms (.100,000 bp
away) influence transcription of the locus is unknown. The
ASVD–associated genetic variants lie within the predicted
structure of a non-coding RNA (ncRNA) called ANRIL. Based
upon recentwork suggesting thatotherncRNAscanrepress
nearby coding genes, we considered the possibility that
ANRIL structure may regulate INK4/ARF gene expression.
Coupling molecular analysis with state-of-the-art sequenc-
ing technologies in a wide variety of cell types from normal
human donors and cancer cells, we found that ANRIL
encodes a heterogeneous species of rare RNA transcripts.
Moreover, we identified novel, circular ANRIL isoforms
(cANRIL) whose expression correlated with INK4/ARF tran-
scription and ASVD risk. These studies suggest a new model
wherein ANRIL structure influences INK4/ARF expression and
susceptibility to atherosclerosis.
cANRIL Expression and Structure
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other INK4/ARF transcripts (e.g. p15
INK4b, p16
INK4a and ARF) since
we previously observed a correlation between the expression of
ANRIL4-6 and p16
INK4a in PBTLs (r
2=0.32, p,0.0001; [42]).
Importantly, none of these Taqman strategies amplify ANRIL
exons containing repetitive sequences. Moreover, the products
from these assays were gel-purified, cloned and sequenced to verify
their identities. Equal amounts of RNA from a panel of 27 primary
and transformed cell lines were subjected to reverse transcription
using a combination of random hexamer and oligo dT primers.
Deletion or methylation of the 9p21 tumor suppressors is a
common event in cancer and was observed in 59% of our cell line
panel (Figure S4). Even after exclusion of these lines from our
analyses, all three ANRIL species (exon 1–2, 4–6 and 18–19) were
rare: based on an estimate of 15 pg of total RNA per cell,
expression of ANRIL species ranged between 0.01 to 1 copy per
cell (Figure 1B). For comparison, INK4/ARF expression is
considered quite low in primary cells [43,44], yet p16
INK4a and
p15
INK4b were more abundant than any ANRIL species in non-
transformed Hs68, HUVEC and IMR90 cell lines (on average
155.9618.9- and 14.565.5-fold, respectively; See Figure S4).
These data indicate that ANRIL species are readily detectable but
non-abundant in a wide variety of cell types.
Central ANRIL exons are weakly detected in cell line and
RNA-seq analyses
To further characterize 9p21 transcription in a manner unbiased
by PCR primer choice, we analyzed publically available, next-
generationRNA sequencing (RNA-seq) datasets of oligo dT-primed
and reverse transcribed RNA from primary human brain or HeLa
cells. ([45]; Genbank Short Read Archive Study ID: SRP002274
and ENCODE RNA-seq replicates, respectively). These datasets
were solely chosen based upon the high-depth of sequencing
provided (.368 million and .110 million reads, respectively),
Figure 1. Identification and characterization of ANRIL splice variants. A, 39 and 59 RACE was performed using primers directed against exons
4 and 6 where long stretches of unique sequence were observed (top). The resulting PCR products were cloned and sequenced, revealing several
novel exons shown in blue (10a and 13b) and multiple non-colinear species (red). B, Equal quantities of total RNA were harvested from growing cell
lines of various tissue types and absolute expression of the indicated transcript was determined. Expression levels are shown in a box-whisker plot on
a log10 scale in 11 of 27 analyzed cell lines which did not harbor homozygous 9p21 deletion. Validated Taqman detection strategies for the indicated
ANRIL species are shown (top).
doi:10.1371/journal.pgen.1001233.g001
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TaqMan-basedanalyses,readsmappingtoANRILwererare inboth
the human brain and HeLa datasets (Figure 2). In fact, the peak
height of reads mapping to p16
INK4a was .40 times higher than that
of any ANRIL exon, even though brain expresses low levels of
p16
INK4a [44,46]. The level of ANRIL expression detected in both
Figure 2. RNA Sequencing of ANRIL transcripts. A, Coverage plots of RNA sequencing reads derived from short read archive study SRP002274
[45]. Top, Read coverage across all ANRIL exons and nearby tumor suppressor genes p16
INK4a, ARF and p15
INK4b is shown. Bottom, The grey regions in
the top panel were graphed on a truncated scale to better depict ANRIL coverage. Annotations above the larger peaks show the maximum number of
reads mapping to these areas. B, Maximum peak height at each exon (normalized by overall locus coverage) is displayed from three independent
samples: SRP002274 (Brain) and two ENCODE RNA-sequencing replicates of the HeLa cell line (HeLa rep 1 and 2). The inset shows all ANRIL exons on
y-axis with peak height of 150 reads.
doi:10.1371/journal.pgen.1001233.g002
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other long, non-coding RNAs including HOTAIR and Kcnq1ot1
(maximal peak heights of 10 and 18, respectively).
Intriguingly, by both TaqMan (Figure 1B) and RNA-seq
(Figure 2B), we observed a disparity in the number of molecules
of each ANRIL exon detected, with those containing the ‘central’
ANRIL (4–12) exons being the least abundant when averaged
across the entire locus. The most prevalent ANRIL peaks localized
to the 59 and 39 ends of the transcript (i.e. exons 1–3 and 13–19).
The relative excess of the more distal exons might be a
consequence of 9p21 deletion, as we observed splicing between
MTAP, a gene 100 kb telomeric to the INK4/ARF locus, and the 39
end of ANRIL in RNA-seq datasets from cell lines with INK4/ARF
loss (i.e. SUM102 and MCF7, data not shown). Although such
MTAP-ANRIL fusions have been previously described [47], using a
highly sensitive Taqman strategy we only detected these fusions in
cell lines with 9p21 deletion, and not in any primary cells or lines
with two copies of an intact INK4/ARF locus (data not shown).
Therefore, while exon deletions and/or MTAP splicing explain the
relative excess transcription of distal ANRIL exons in some cancer
cell lines harboring 9p21 deletion, these mechanisms do not
explain the decreased transcription of exons 4–12 versus exons 1–
3, in any cell line. Likewise, somatic deletions and MTAP splicing
do not explain the uniform decrease of the central exons compared
to the proximal and distal exons in cultures of primary cells (Figure
S4). Together, these RNA-seq and TaqMan analyses indicate that
ANRIL is a rare, multi-variant RNA species in which transcripts
containing exons 1–3 or 13–19 predominate over those containing
exons 4–12. Based on these findings as well as the observation of
non-colinear RNA species by RACE (Figure 1A), we hypothesized
that the reduced level of the central exons (4–12) in mature,
polyadenylated RNA may be the result of alternative splicing
events in which the central exons of ANRIL are frequently skipped.
Select ANRIL transcripts containing internal exons are
circular
We observed non-colinear RNA species in RACE analysis of
several cell lines and primary cells (Figure 1A). We considered the
possibility that this represented alterations of the germline DNA
sequence (e.g. duplications or transversions) but found no evidence
for this using BreakDancer [48] to analyze next-generation DNA
sequencing from 10 individuals. Given that cryptic germline DNA
alterations did not appear to explain these non-colinear forms, we
considered that non-canonical RNA splicing events such as trans-
splicing or re-splicing of RNA lariats might occur as part of ANRIL
processing. In the latter case, the splice sites of certain consecutive
exons are not recognized by the splicing machinery, resulting in
the inclusion of exonic sequences within the RNA lariat [49].
Internal splicing of this exon-containing lariat structure may then
occur, leading to the production of exon-only RNA circles in
which non-consecutive exon junctions are generated by splicing
across the branch site (e.g. exon 13–14–4–5).
To determine the structure of such non-colinear ANRIL RNAs,
we designed and validated a Taqman strategy using outward
facing primers to detect transcripts containing the non-colinear
exon 14-5 junction (Figure 3A). This detection scheme was chosen
based upon preliminary PCR studies wherein amplification of the
14-5 splice junction predominated over that of the exon 14-4
junction. As lariat or circular RNAs would not be polyadenylated,
we assayed the amount of each ANRIL species detected in RNA
samples reverse transcribed with random hexamers (HEX), oligo
dT (dT) or both (Figure 3B). As would be expected for
polyadenylated RNAs, conversion of ANRIL1-2, ANRIL18-19,
p16
INK4a and p15
INK4b into cDNA was efficiently accomplished
with either oligo dT or HEX primers alone. Conversely, ANRIL4-
6 and 14-5 were effectively primed with HEX but not oligo dT,
confirming that these transcripts were not polyadenylated.
To further examine the structure of these non-canonical
transcripts, we determined transcript sensitivity to the RNA
exonuclease, RNAse R. RNAse R specifically digests both
structured and non-structured linear RNAs, but spares RNA
circles and lariats [50]. Using equal amounts of RNA from normal
and immortalized human fibroblasts (IMR90 and Hs68, respec-
tively) treated with or without RNAse R, we generated cDNA and
conducted TaqMan analysis for ANRIL expression. As expected
for linear species, RNAse R treatment caused a marked reduction
in the number of p16
INK4a and p15
INK4b transcripts detected (4.5-
and 8.4-fold decrease, respectively), demonstrating that these
coding transcripts are predominantly linear (Figure 3C and 3D). In
contrast, we observed a 6-fold enrichment of ANRIL14-5
molecules with RNAse R treatment, confirming their circular
nature. We were surprised to find that ANRIL4-6 expression also
exhibited RNAse R-dependent enrichment in both cell lines.
ANRIL1-2 levels decreased consistent with a predominantly linear
species, and ANRIL18-19 demonstrated an intermediate behavior
consistent with a mix of linear and circular forms (Figure 3C and
3D). Together, these data provide evidence that ANRIL4-6 and 14-
5 are predominantly contained within non-polyadenylated,
circular (or lariat) ANRIL (cANRIL) transcripts.
Circular ANRIL species are observed in a wide variety of
cell types
Based upon analysis of non-sequential cDNA and EST
sequences, stable RNA circles have been hypothesized to represent
,1% of the total transciptome [51]. To determine the ubiquity of
cANRIL RNAs, we employed the Taqman-based strategy shown in
Figure 3A. Using this method, we observed amplification of
ANRIL14-5 in 16 of 20 ANRIL expressing primary cultures and cell
lines (Figure S5). The finding of cANRIL in diverse cell types is
perhaps surprising given the low abundance of ANRIL transcripts
and that RNA lariats are usually unstable intermediates which
undergo rapid degradation. These data suggest that cANRIL is a
stable, naturally occurring, circular RNA species produced in most
INK4/ARF expressing cells.
To better define the structure of cANRIL RNAs, we used
outward-facing primers located in five ANRIL exons to amplify
cDNA produced using a mix of random hexamers and oligo dT
(Figure 4A). In Hs68 and IM90 cells, PCR products specific to
9p21 were detected using primers sets targeting exons 4 and 6.
These products were more efficiently amplified using cDNAs from
RNase R-treated samples, suggesting that they arose from circular
RNAs. In contrast, PCR products specific to chromosome 9 were
not detected using primers internal to exons 1 and 18, and only
detected in one instance with primers internal to exon 16,
suggesting these exons were not commonly included in stable,
circular ANRIL species. To determine the contents of the circular
transcripts containing ANRIL exons 4 and 6, we cloned and
sequenced the observed PCR products. The resulting sequences
predominantly included ANRIL exons 4 to14. Several exons were
never observed in the looped structures (i.e. exons 1, 2, 3, 8, 9, 11,
and 12) (Figure 4B and 4C). Novel sequences were also discovered
within the products, most notably, regions intronic to the
previously described ANRIL transcript (i.e. parts of intron 3).
These data explain the paucity of expression of ANRIL exons 4 to
14 as determined by Taqman and RNA-seq (Figure 1B and
Figure 2B), suggesting that ANRIL processing may involve exon
skipping events which preferentially incorporate the central exons
into lariats which may then be internally spliced to form cANRIL.
cANRIL Expression and Structure
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correlate with INK4/ARF expression and ASVD–associated
SNP genotype
We have previously shown [42] a correlation between
expression of the coding INK4/ARF transcripts and ANRIL4-6.
We now recognize that the latter is largely contained in circular
RNA species (Figure 3B and 3C). Next, we investigated
correlations between other, newly identified ANRIL isoforms and
the coding INK4/ARF transcripts (Figure 5A and Figure S6). We
performed Taqman-based gene expression analyses in 106
primary human peripheral blood T-lymphocyte (PBTL) samples
from two previously published cohorts [16,42]. Remarkably,
cANRIL expression (ANRIL14-5 and ANRIL4-6) was observed in all
PBTL samples. Expression of ANRIL18-19 did not correlate with
Figure 3. ANRIL 14-5 and 4-6 are circular RNAs. A, Schematic representation of the ANRIL14-5 Taqman detection strategy wherein the probe (red)
spans the exon 5-exon 14 boundary amplified with outward facing primers. B, Expression of the indicated transcripts was quantified in cDNA from
Hs68 cells made using the indicate primers (-RT: no reverse transcriptase, H+dT: an equal mix of random hexamers and oligo dT, dT: oligo dT alone,
and HEX: random hexamers alone). Error bars represent the standard deviation for three replicates. C, Total RNA harvested from growing Hs68 (top)
and IMR90 (bottom) cells was incubated with our without RNase R, purified and reverse transcribed. The indicated transcripts were quantified in ‘B’.
D, The average fold enrichment by RNase R for each transcript is shown on a log10 scale.
doi:10.1371/journal.pgen.1001233.g003
cANRIL Expression and Structure
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a strong correlation was observed between the expression of
ANRIL4-6 and all of the INK4/ARF tumor suppressors
(p,1*10
215 for all pair-wise comparisons). Significant associations
(p,0.05) were also observed between ANRIL1-2 and ARF, and
between ANRIL14-5 and p16
INK4a.
We have also demonstrated an effect of a replicated SNP
associated with atherosclerosis (rs10757278) on the expression of
p15
INK4b, p16
INK4a, ARF and ANRIL4-6 in PBTLs [16]. We
therefore examined whether expression of other ANRIL isoforms
correlated with ASVD SNP genotype (Figure 5B). While no
significant correlation between ANRIL18-19 with SNP genotype
was noted, expression of ANRIL1-2 and ANRIL14-5 showed
significantly decreased expression in individuals harboring the risk
(G) allele (p,0.0001 and p,0.04, respectively). In aggregate, these
data demonstrate that expression of both circular and linear
transcripts containing the proximal but not distal ANRIL exons
correlates with ASVD-SNP genotype and expression of the coding
INK4/ARF transcripts.
Deep sequencing of the ASVD risk interval reveals ANRIL
exon 15 variants predicted to influence cANRIL
production
We performed next-generation DNA sequencing of the ASVD
risk interval to identify polymorphisms that might influence ANRIL
expression or splicing. To enhance detection of rare variants, we
pooled DNA from 5 individuals of Asian and European descent
who were homozygous for either the A or G allele of rs10757278.
To increase the chance that the analyzed DNAs would harbor
causal variants that influence INK4/ARF expression, we selected
individuals based on their age-adjusted expression of p16
INK4a (i.e.
AA donors with higher than average expression, GG donors with
lower than average expression [16]). We performed sequence
capture using an Illumina tiling array on the AA vs. GG pooled
samples. The tiling array was designed to bind all non-repetitive
human chromosome 9 regions from 22,054,888 to 22,134,171 bp,
a region chosen as it contains the previously identified ASVD and
type 2 diabetes mellitus risk intervals (Figure 6A). The 9p21
enriched DNA was sequenced using both Roche 454 (400 bp
reads) and Illumina GAII (35 bp reads) technologies. The resulting
sequences were aligned to the UCSC reference genome (hg18)
using three separate alignment algorithms: gsMapper, BWA and
SOAP [52,53]. As shown in Figure 6B, SOAP identified the
highest number of polymorphisms within each pooled sample;
however, many of these were not recapitulated using other
mapping techniques. Thus, for further analysis we focused our
efforts on polymorphisms which were identified by at least two
mapping algorithms. Employing these criteria, we discovered 101
SNPs that differed from the reference genome within our samples:
11 in the AA pool, 64 in the GG pool, and 26 in both (Figure 6C).
Figure 4. ANRIL circular RNAs predominantly contain exons 4-14. A, cDNA generated in the presence (+R) or absence (-R) of RNase R as in
Figure 3C was subjected to PCR using outward facing primers within the same exon as depicted (left) and separated by gel electrophoresis. B and C,
The PCR products in ‘A’ were purified, cloned and sequenced. The resulting sequences are shown for each exon pair.
doi:10.1371/journal.pgen.1001233.g004
cANRIL Expression and Structure
PLoS Genetics | www.plosgenetics.org 7 December 2010 | Volume 6 | Issue 12 | e1001233As expected, more differences from the reference genome were
identified in the GG sample, as the reference genome harbors the
A allele, and most SNPs in the captured region are in moderate to
strong linkage disequilibrium with rs10757278 (Figure S1).
Therefore, using next generation sequencing of captured DNA
from 10 informative individuals biased to harbor causal variants,
the chosen sequencing approach found 75 (11+64) SNPs that
differed between the two pooled samples.
Given the finding that cANRIL expression correlates with
rs10757278 genotype, we sought to determine if any of the
identified SNPs might influence ANRIL splicing. For this analysis,
we restricted the SNP list to include only those within 200 bp of an
ANRIL intron-exon boundary, as genetic alterations in this region
have the highest potential to influence RNA splicing [54]. Of the
75 SNPs present in only one of the two pooled samples, four were
within 200 bp of an ANRIL intron-exon boundary (Figure 6C,
Table S1). Using previously described prediction algorithms
[54,55], we determined the likelihood of these variants near
intron-exon boundaries to change cis-regulatory splice elements
including exon splicing enhancers (ESEs) and silencers (ESSs) as
well as intronic splicing enhancers (ISEs) and silencers (ISSs). A
score of -1 indicates that the minor allele destroys one cis-element
and +1 indicates that the minor allele creates one cis-element
(Table S1). ESEs and ISEs favor exon recognition by the
spliceosome when they occur in exons or introns, respectively.
However, ISSs and ESSs promote exon skipping irrespective of
position [56]. A pair of SNPs (rs34660702 and NOVEL) 10 bp
apart near the start of exon 12 were predicted to alter ANRIL
splicing, but the effects of these SNPs worked in opposite
directions, and both exhibited low frequencies in the CEU
population (Figure 6C and Table S1). More provocatively, we also
observed two SNPs (rs7341786 and rs7341791) in strong linkage
disequalibrium with rs10757278 and which bracketed exon 15.
These SNPs demonstrated high minor allele (CC and GG,
respectively) frequencies and with the major allele of both SNPs
enhancing the ‘‘exon-ness’’ of exon 15. These results indentify
common, linked SNPs whose major allele is likely to inhibit
skipping of exon 15 and thereby promote the production of
cANRIL species ending in exon 14 in individuals homozygous for
the A (protective) allele of rs10757278.
Due to the small number of pooled individuals for sequencing
(n=5/group), we also sought to identify additional, rare
polymorphisms with the potential to modulate ANRIL splicing.
We analyzed all SNPs reported in the HapMap database in the
chromosome 9 region 22,054,888 to 22,134,171 within 200 bp of
ANRIL intron-exon boundaries for their potential to alter RNA
Figure 5. ANRIL4-6 and 14-5 correlate with INK4/ARF expression and rs10757278 genotype in human PBTLs. A, Taqman anlaysis of ANRIL
and INK4/ARF transcripts was conducted and normalized as described in Materials and Methods. Correlations between ANRIL and INK4/ARF transcripts
in 106 primary peripheral blood T-lymphocytes (PBTLs) were determined using linear regression. The R value for each pair-wise comparison is shown,
with those achieving significance (p,0.05) depicted in blue. Due to limitations in sample availability, ANRIL 1-2 and ANRIL 14-5 levels were
determined in only a subset of individuals (n=94 and 98, respectively). B, The relative expression of ANRIL1-2, 14-5 and 18-19 normalized as in ‘A’ is
plotted versus rs10757278 genotype. p-values were determined by a two-sided t-test.
doi:10.1371/journal.pgen.1001233.g005
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SNPs in HapMap that modified ESE, ESS, ISE or ISS sequences
(Table S1). Notably, the majority of these variants were rare and
almost never reported in the CEU population [57]. Therefore,
among all of the SNPs examined from the ASVD risk interval,
rs7341786 and rs7341791 appear most likely to influence ANRIL
splicing. These SNPs are also in very strong linkage disequilibrium
with the ASVD-associated SNP, rs10757278 (r
2.0.96, based upon
the nearest database SNPs in CEU), and therefore would be
expected to correlate with ANRIL and INK4/ARF expression.
However, it is important to note that other classes of germline
variants (e.g. complex indels or alterations in repetitive elements)
would not have been identified by our sequencing strategy, and
therefore we are unable to exclude a role for other such variants in
ANRIL expression and/or splicing.
Discussion
Motivated by the role of other long, non-coding RNAs in PcG
repression, we investigated whether ANRIL transcription and/or
structure was SNP-dependent. In primary and cultured cell lines,
we used RACE and RNA-seq to identify novel ANRIL variants
(Figure 1 and Figure 2). Intriguingly, the central ANRIL exons
were underrepresented in these data (Figure 1B and Figure 2B).
This observation, along with non-colinear products detected by
RACE, led to the unexpected discovery of multiple circular RNAs
emanating from the ANRIL locus. Sequencing of these circular
species showed non-sequential linkages between various ANRIL
exons, especially those from the central portion of the transcript
(e.g. exons 4-14) (Figure 4B and 4C). Expression of both circular
and linear ANRIL isoforms proximal to the INK4/ARF locus
strongly correlated with INK4/ARF transcription and the ASVD
risk genotype at rs10757278 (Figure 5 and Figure S6). In contrast,
distal ANRIL variants containing exons 18 and 19 were expressed
in a genotype-independent manner and did not correlate with the
levels of any INK4/ARF transcript. Using next-generation
sequencing to genotype captured DNA from the ASVD risk
interval, we identified a common pair of linked SNPs near exon 15
predicted to influence ANRIL splicing (Figure 6 and Table S1).
Together, these findings suggest that common polymorphisms in
the ASVD risk interval could modulate ANRIL transcription and/
or splicing, thereby influencing PcG-mediated INK4/ARF repres-
sion and atherosclerosis susceptibility.
ANRIL encodes multiple, non-abundant linear and
circular species
Multiple ANRIL isoforms have been reported in the literature
and EST databases, with some exhibiting differential expression
patterns and SNP associations (Figure S2 and [28,29]). Using
RACE, RNA-seq and sensitive quantitative real-time PCR
techniques, we now show that no single ANRIL species
predominates in vivo, and that splicing to MTAP does not occur
in cells with an intact 9p21 locus. Moreover, our analyses
identified new ANRIL exons and variants, uncovering a novel
Figure 6. Deep sequencing of 9p21 in pools of rs10757278 homozygotes. A, The region captured using DNA sequence capture technology
is shown on the ‘Tiling’ track. The ‘Unique’ track shows the Duke 35 bp Uniqueness information as provided in the UCSC Genome Browser. The bar at
the top of the figure represents the 53 kb risk interval previously defined by Broadbent et al. [13]. B, Venn diagrams depicting SNP calls for the AA
(left) and GG (right) samples using three different algorithms. C, Using the UCSC Genome Browser, SNPs identified by next-generation DNA
sequencing are depicted across the captured region of 9p21. The ‘Discovered’ track shows the polymophisms identified by two or more algorithms in
either the pooled AA or GG sample. SNPs unique to each genotype are shown below. The ‘Unique Splice’ track depicts the location of the 4 SNPs,
unique to the GG sample, which modify cis-acting splice regulation sites (See also Table S1).
doi:10.1371/journal.pgen.1001233.g006
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independent approaches, we found that all ANRIL exons were
expressed at very low levels, orders of magnitude lower than even
the relatively rare INK4/ARF tumor suppressors, p15
INK4b and
p16
INK4a (Figure 1B, Figure 2B, and Figure S4). This low level of
expression is comparable to what we observed for other regulatory
non-coding RNAs (i.e. HOTAIR and Kcnq1ot1) associated with
PcG-mediated repression.
The discovery of non-colinear ANRIL species whose expression
correlated with INK4/ARF transcription suggested that alternative
splicing events might modify ANRIL structure leading to changes
in PcG-mediated INK4/ARF repression. There are two major
mechanisms by which non-colinear RNAs are thought to arise:
trans-splicing and exon skipping [58]. During trans-splicing, a Y-
branched RNA structure is formed that is sensitive to RNase R
digestion [50]. In contrast, exon skipping events generate large
lariat structures, which can then undergo cis-splicing to create
RNase R-resistant circular RNAs. To confirm the circular nature
of the ANRIL species, we showed that transcripts containing
ANRIL4-6 and 14-5 were resistant to RNase R degradation, were
not polyadenylated and could be PCR amplified using sets of
outward facing primers (Figure 3 and Figure 4). Therefore,
cANRIL species appear to result from exon skipping events
occurring during RNA splicing.
INK4/ARF regulation and ASVD genotype
Based on these observations, we propose a model suggesting
that common polymorphisms in 9p21.3 modifiy INK4/ARF gene
expression through cis-regulation of ANRIL transcription and/or
splicing (Figure 7). In turn, such changes in ANRIL levels or
structure influence the ability of these ncRNAs to repress the
INK4/ARF locus. Specifically, changes in PcG-mediated repression
of p15
INK4b, p16
INK4a and/or ARF occur, altering potentially
atherogenic cellular proliferation and ASVD risk as previously
suggested [16–20,26].
Prior studies provide evidence for this model. For example, we
and others have described an effect of ASVD-genotype on ANRIL
transcription [16,30,59,60]. Moreover, meticulous allele-specific
expression analyses by Cunnington et al. suggested that the cis-
effects of 9p21 SNPs were stronger for ANRIL than for the coding
INK4/ARF transcripts (20% vs. ,8%)[60]. In contrast, the effect of
these SNPs on expression of the coding INK4/ARF transcripts
predominantly occurred in trans-. Such findings are consistent with
our model whereby causal variants directly influence ANRIL
structure in cis-, thereby controlling repression of the INK4/ARF
locus, possibly in trans- (Figure 7). Likewise, recent work has
supported a role for ncRNAs in INK4/ARF repression. Knock-
down of the RNA helicase, Mov10, led to INK4/ARF deregulation,
suggesting a role for RNA metabolism in regulation of the locus
[61]. Supporting these data, Yap et al. recently demonstrated that
the 59 end of ANRIL contains stem-loop structures capable of
binding CBX7, a member of the PRC-1 complex [62]. Disruption
of this interaction led to premature senescence marked by
increased INK4/ARF expression. Therefore, strong evidence
supports the notion that ANRIL expression correlates with
ASVD-SNP genotype and that PcG-mediated repression of the
INK4/ARF locus is modulated by this expression.
The outstanding question of this model is the biochemical
mechanism whereby causal variants at 9p21.3 located more than
100 kb distant from the proximal exons of ANRIL (Figure S1)
modulate ANRIL expression and/or structure. Our data are
consistent with a ‘‘transcriptional model’’ wherein distal cis-
regulatory elements within the ASVD risk interval directly
influence ANRIL transcription. Jarinova et al. have identified an
enhancer sequence within ANRIL intron 17, which in heterologous
reporter assays, enhanced transcription in a genotype-specific
Figure 7. Model showing how 9p21 polymorphisms influence ANRIL isoform production to modulate INK4/ARF gene transcription.
PcG complexes (e.g. PRC-1) are targeted to the coding INK4/ARF locus by ANRIL, and modulate its repression. Nascent ANRIL transcripts are spliced to
produce circular ANRIL species (cANRIL). Causal variants in the ASVD risk interval modulate ANRIL transcription or splicing to influence INK4/ARF
expression. See discussion for further description.
doi:10.1371/journal.pgen.1001233.g007
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significant effect of ASVD-SNP genotype on the expression of the
linear ANRIL1-2 transcript (Figure 5B). As such, the correlation of
cANRIL expression with ASVD-SNP genotype would presumably
reflect passive production of these circular species in the setting of
increased or decreased in total ANRIL transcription. However, this
model would not easily explain the positive correlation we
observed between the expression of coding INK4/ARF transcripts
and proximal ANRIL exons (Figure 5A and Figure S6), as the
59end of ANRIL is reported to foster INK4/ARF repression [62].
Alternatively, we believe our present data are more consistent
with a ‘‘splicing model’’ in which causal variants in the ASVD risk
interval influence ANRIL splicing by regulating exon skipping.
Provocatively, the ASVD risk interval includes exon 15 where the
termination of most exon skipping events that produce cANRIL
occur (Figure 4B and 4C). Using next-generation sequencing of
this region in individuals biased to harbor causal variants, we
identified exon 15 SNPs (rs7341786 and rs7341791) which are in
strong linkage disequilibrium with the ASVD-associated SNP
rs10757278 (r
2.0.96; Table S1). These polymorphisms have high
minor allele frequencies in our sample and the CEU population
and are predicted to alter ANRIL splicing (Figure 6, Table S1). In
particular, the major allele (‘A’) of rs7341786, detected only in
individuals homozygous for the A-allele at rs10757278, is
predicted to increase the strength of exon 15 as a splice acceptor,
which would promote the expression of spliced RNA circles
ending in exon 14, as observed (Figure 4B and 4C).
For the splicing model to explain the observed positive
correlation between the expression of ANRIL and the coding
INK4/ARF transcripts, distinct species of ANRIL would need to
differ in their ability to repress the INK4/ARF locus. Supporting
this possibility, PcG-mediated repression of the murine Kcnq1 locus
is dependent upon the length of the long, ncRNA, Kcnq1ot1
[63,64]. Specifically, longer Kcnq1ot1 transcripts are associated
with increased PcG recruitment and Kcnq1 silencing potential.
Therefore, shorter ANRIL variants (i.e. those lacking exons 4–16)
generated by exon skipping events may also be less efficient at
repressing the INK4/ARF locus. Important predictions of the
splicing model are that cANRIL expression (reflecting ANRIL
splicing) should correlate with INK4/ARF expression (which it
does, Figure 5A and Figure S6), that individuals homozygous for
the ‘A’ allele of rs7341786 (and rs10757278) should exhibit
increased production of cANRIL species containing exon 14 but
not exon 15 (which they do, see Figure 4B and 4C) and that these
individuals with increased propensity for splicing should exhibit
de-repressed INK4/ARF expression (which they do, [16]).
A caveat to the splicing model is that the identified exon 15
SNPs need not be the true causal variant(s) influencing ANRIL
splicing. It is possible that other polymorphisms not detected by
our sequencing strategy could regulate ANRIL splicing. In
particular, the sequencing strategy employed would not find
differences between the pooled samples in repetitive regions, such
as the large LINE element in the 12
th intron of ANRIL (Figure 6A).
ANRIL harbors several LINE and SINE elements, and such
repetitive motifs have been reported to modulate RNA splicing in
other systems [65,66]. Therefore, while the exon 15 SNPs appear
to be prime candidates to regulate ANRIL splicing, a variety of
other classes of polymorphisms could also influence splicing and
would not have been observed by the chosen sequencing
approach.
Importantly, the splicing and transcriptional models are not
mutually exclusive. A single causal variant may influence both
processes or there may be multiple causal variants that influence
either process within the ASVD risk interval. Finally, while we
believe the correlation of cANRIL expression and ASVD-SNP
genotype is most likely explained by an effect of common 9p21
polymorphisms on transcription and/or splicing, a third possibility
also exists. While circular RNA byproducts of exon skipping have
generally been regarded as inconsequential, circular RNAs with
catalytic activities (e.g. group I and some group II introns) are well
described in bacteria, lower eukaryotes, plants [67]. In addition,
some viroids and the hepatitis delta satellite virus have circular
RNA genomes [68,69]. Although we are not aware of any
endogenously produced circular RNA with discrete function in
mammals, clearly circular RNAs species can possess independent
functions in non-mammalian species, and we remain open to the
possibility that cANRIL itself can directly participate in INK4/ARF
regulation.
In summary, this work links ASVD-genotype to ANRIL
structure and INK4/ARF regulation, providing evidence for what
we believe is a first association between endogenous circular RNA
expression and a mammalian phenotype (ASVD). Even were
cANRIL expression merely a marker of exon skipping with no
specific biologic function, we believe its expression may be a useful
marker of ANRIL isoform selection, which our findings suggest is of
pathogenic relevance to ASVD susceptibility. We believe this work
has implications beyond ASVD, as altered ANRIL splicing could
influence INK4/ARF expression, explaining the association of
other nearby 9p21 SNPs with a variety of non-ASVD phenotypes
in humans including longevity, type II diabetes, endometriosis and
several tumors types [70–77].
Materials and Methods
Ethics statement
Research involving human subjects was approved by the
University of North Carolina Institutional Review Board and all
participants provided informed, written consent.
Cell lines and culture conditions
WM266-4, UACC 257, A2058, A375, SUM-149, RPMI-8322
and telomerized Hs68 cells were obtained and grown as previously
described [78–80]. MDA-MB-468, MDA-MB-436, MDA-MB-
231, MCF7, BT-474, BT-549, T-47D, COLO 205, T84, LoVo,
LS 174T, SW480, LS1034, HeLa, HUVEC, IMR90, Ramos,
Raji, Jurkat and U-87 cells were originally obtained from ATCC
and cultured as suggested.
39 and 59 rapid amplification of cDNA ends (RACE)
CD3 positive T-cells were isolated from human peripheral
blood samples as previously described [42]. RNA was generated
from proliferating cell lines and isolated human T-cells using the
RNAeasy system (Qiagen Inc., Valencia, CA). 39 and 59 RACE
was performed as described in the Firstchoice RLM-RACE
manual (Ambion Inc., Austin, TX). This procedure is optimized
for the detection of rare transcripts and provides additional steps to
improve the specificity of mRNA amplification. Gene-specific
primers were designed within ANRIL exons 4 and 6 as shown in
Figure 1A and Table S2; RACE primers for other ANRIL exons
tested did not amplify chromosome 9 specific products. All PCR
reactions were conducted using SuperTaq-Plus (Ambion) in a Bio-
Rad DNA Engine thermocycler. SuperTaq-Plus is a high fidelity,
long range polymerase with the capability to amplify complex
DNAs such as repetitive SINE, LINE and Alu elements. Cycling
conditions for 59RACE were: 94uC 3 min, 346[94uC3 0s ,6 0 uC
30 s, 68uC 3 min], 68uC 5 min (inner reaction) and 94uC 3 min,
346[94uC3 0 s ,6 2 uC3 0 s ,6 8 uC 3 min], 68uC 5 min (outer
reaction). Cycling conditions for 39RACE were: 94uC 3 min, 346
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94uC 3 min, 346[94uC3 0 s ,6 0 uC3 0 s ,6 8 uC 3 min] (inner
reaction). Cloning of the resulting PCR products was conducted
using the TOPO-Blunt cloning kit (Invitrogen). Sequencing of the
resulting clones was conducted using both M13F and M13R
primers.
Quantitative real-time PCR (qRT-PCR)
RNA was isolated using the Qiagen RNAeasy Kit and subjected
to reverse transcription using the ImPromII reverse transcription
system (Promega, Madison, WI). RNA samples from breast and
colorectal cell lines were kindly provided by Drs. N. Mitin and J.
Yeh (UNC). Taqman primer and probe sets for the detection of
ANRIL exons 1–2, 4–6, 14–5, and 18–19 as well as those for
p15
INK4b, p16
INK4a, ARF and 18S rRNA are described in Table S2.
The ANRIL primer sets were designed to span at least one intron
and were shown to have high specificity with linear amplification
efficiencies between 88 and 94% (Figure S3). Final primer and
probe concentrations were 900 and 250 nM, respectively.
Products from the ANRIL 1–2, 4–6, 14–5 and 18–19 qRT-PCR
reactions were cloned separately into the pBluntII-TOPO vector
(Invitrogen) and verified. Real-time PCR was carried out in
triplicate on an ABI 7900HT thermocyler.
For relative expression studies, differentials were first calculated
between each sample and the average 18S cycle threshold (Ct) for
the entire experiment. Transcript Ct values were normalized using
the equation: Expression = Lower limit of detection (37 or 40) -
(Ct target –C t18S differential) and plotted on a log2 scale. The relative
expression of p16
INK4a, p15
INK4b, ARF and ANRIL4-6 in PBTLs has
been previously reported [42]; in this work, these same samples
were reanalyzed for ANRIL1-2, ANRIL14-5 and ANRIL18-19
expression as shown in Figure 5 and Figure S6. In Figure 5 and
Figure S6, data was corrected to account for batch effects between
the pilot and verification datasets previously described [42]. To
determine the absolute number of transcripts present, a standard
curve of five dilutions was generated for each experimental plate
using known amounts of linearized plasmid containing the target
sequence. The number of molecules detected in each sample was
calculated using the equation: #Molecules = 10‘((Ct – y-
intercept)/slope). Primer efficiencies were calculated using the
equation: Efficiency = (10‘(-1/slope))-1. Multiple comparison
plots and statistical analysis appearing in Figure 5A and Figure S6
was performed using the gpairs function of the R YaleToolkit
library.
Analysis of RNA-seq data
A total of 368,846,235 reads generated on the Illumina platform
(study SRP002274) were downloaded from the NCBI Short
Read Archive. The reads were first screened for unique 20mers
deriving from chromosome 9:21,700,000–22,300,000 using the
UCSC genome bowser Duke uniqueness mapability table. The
resulting reads were mapped using the TopHat spliced aligner
(PMID: 19289445) to the reference human genome (hg18). The
resulting coverage plot was imported into the UCSC genome
browser for display. Also analyzed were two independent CalTech
ENCODE mRNA-seq datasets (http://genome.ucsc.edu/cgi-bin/
hgTrackUi?g=wgEncodeCaltechRnaSeq) from HeLa cells. These
datasets were chosen because they lacked deletion of 9p21 and
showed the highest level of ANRIL expression of any publically
available RNA-seq data we analyzed. For Figure 2B, the peak
number of reads at a given base (SRP002274 data) or peak reads
per kilobase mapping (CalTech HeLa data) were quantified and
scaled relative to the average exonic coverage.
RNase R digestion
Total RNA was isolated from proliferating Hs68 and IMR90
cells using a Qiagen RNAeasy kit. Equal amounts of RNA (43–
50 mg, depending on the experiment) were incubated with or
without 40 U of Rnase R (RNR07250, Epicentre Biotechnologies)
for 2.5 hours at 37uC. The resulting RNA was purified using the
RNAeasy column and quantified. Equal amounts of RNA were
then subjected to reverse transcription using the ImPromII reverse
transcription system and a mixture of random hexamer and oligo
dT primers (Promega, Madison, WI). Transcripts were quantified
using Taqman-based real-time PCR.
Loop PCR
PCR primers pointing in opposite directions on ANRIL exons 1,
4, 6, 13, 16 and 18 were designed using Primer3 software and
analyzed for hairpins using Netprimer (Premier Biosoft and
http://frodo.wi.mit.edu/primer3/) (Table S2). PCR reactions
were conducted using cDNA representing 15 ng of mock or
Rnase R-treated RNA. Reactions were performed using Apex Hot
Start Taq DNA polymerase and Buffer 2 (Genesee Scientific) in a
Bio-Rad DNA Engine thermocycler. The cycling conditions were
as follows: 95uC 15 min, 406[94uC3 0s ,5 9 uC3 0s ,7 2 uC 1 min],
72uC 2 min. The resulting PCR products were cloned into the
TOPO-Blunt cloning kit (Invitrogen) and sequenced using M13F
and M13R primers.
Sequence capture and next-generation sequencing
Genomic DNA was generated from T-cells of healthy human
volunteers of known rs10757278 genotype, age and p16
INK4a
expression status using the Qiagen Peripheral Blood DNA
isolation kit. For sequence capture, 21 ug of DNA was pooled
from five individuals homozygous for the G-allele of rs10757278
and another five individuals homozygous for the A-allele. Samples
were sent to NimbleGen for sequence capture using a tiled array
spanning human chromosome 9 (22,054,888-22,134,171). The
resulting amplified DNA fragments were analyzed at the UNC
Genome Analysis Facility using both Illumina GAII and Roche
454 technology. For sequencing on the Illumina platform, DNA
was randomly sheered and appropriate adapters ligated. Resulting
sequences were aligned to the entire human genome (hg18) using
MAQ, SOAP, and gsMapper software [52,53]. MAQ was run
with default settings and output was translated into BAM format.
SOAP alignment was performed allowing up to 10 gap bases and 2
mismatches and also translated into BAM format. Mapping with
gsMapper was performed with default settings. SNP calls from
MAQ and SOAP were generated using the pileup function of the
SAMtools library [81]. Calls were culled to include only those
SNPs appearing in $20 percent of reads.
Supporting Information
Figure S1 Polymorphisms within the INK4/ARF locus linked to
age-related diseases. A, Schematic diagram of the 9p21 locus
depicting the INK4/ARF tumor suppressors, ANRIL and the ASVD
risk interval. The captured (‘‘tiling’’) region for next generation
DNA sequencing is indicated. B, The localization of SNPs linked
in the literature to age-related diseases including is shown. T2D-
type II diabetes, CAD- coronary artery disease, MI-myocardial
infarction, AD-Alzheimer’s disease C, A heatmap depicting the
SNP linkage disequilibrium (D9/LOD) was generated from the
Hapmap CEU population using Haploview software. The strength
of linkage disequilibrium increases from white to blue to red: white
(disequilibrium coefficient (D9),1 and LOD score ,2); blue
(D9=1 and LOD score ,2); pink (D9,1 and LOD score $2); and
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the depicted 9p21 image as shown in the diagram above.
Found at: doi:10.1371/journal.pgen.1001233.s001 (1.37 MB TIF)
Figure S2 Schematic of previously reported ANRIL variants. All
Ensembl (blue) and GenBank (black) records for ANRIL
(CDKN2BAS) are shown. Some sequences are derived from cDNA
sequencing whereas others were inferred by EST assembly.
Found at: doi:10.1371/journal.pgen.1001233.s002 (0.64 MB TIF)
Figure S3 Efficiency curves for Taqman probe strategies.
Cloned cDNAs or PCR products corresponding to the Taqman
target sequences were linearized and quantified. For each realtime
PCR run, a standard curve of 5 independent dilutions was run in
triplicate. Primer efficiency was calculated using the formula:
Efficiency =10‘(-1/slope)-1. Shown are representative graphs
from individual experiments.
Found at: doi:10.1371/journal.pgen.1001233.s003 (0.52 MB TIF)
Figure S4 Expression of 9p21 transcripts in transformed and
non-transformed cell lines. As described in Figure 1B, RNA was
harvested, reverse transcribed and quantitative real-time PCR
performed. Bars represent the log10 of the average number of
molecules detected. The error bars denote the standard deviation
between three replicates. The letter ‘D’ denotes deletion events
previously reported in the literature. ‘M’ indicates gene methyl-
ation. Breast cancer are shown in pink, colorectal cancers in blue,
melanomas in black, hematological malignancies in green, cervical
carcinomas in turquoise, glioblastomas in gold and nontrans-
formed cells in red.
Found at: doi:10.1371/journal.pgen.1001233.s004 (0.58 MB TIF)
Figure S5 ANRIL14-5 expression is detected in a wide variety of
cell types. cDNA generated as described in Figure 1B was assayed
for ANRIL14-5 expression using the Taqman strategy shown in
Figure 3A. Bars represent the log10 of the average number of
molecules detected. The error bars denote the standard deviation
between three replicates. Cell lines are color coded as in Figure S4.
Found at: doi:10.1371/journal.pgen.1001233.s005 (0.50 MB
TIF)
Figure S6 Correlation of ANRIL and INK4/ARF expression in
primary peripheral blood T-lymphocytes. Diagram depicting the
correlations between 9p21 transcripts in primary peripheral blood
T-lymphocytes from 106 patients. Taqman anlaysis of ANRIL and
INK4/ARF transcripts was conducted and normalized as described
in Materials and Methods. Data for ANRIL4-6, p16
INK4a, p15
INK4b
and ARF expression were previously reported [42]. Scatter plots,
below the diagonal, show the relationships between all pairs of
transcripts on a log2 scale. Linear regression is depicted in red.
Boxes above the diagonal list and are color coded by r-value. A
star (*) indicates significant associations (p,0.05). Histograms
along the diagonal show the distribution of expression for each
transcript assayed. Due to limitations in sample availability, ANRIL
1-2 and ANRIL 14-5 levels were not determined for several
individuals as indicated (n=94 and 98, respectively).
Found at: doi:10.1371/journal.pgen.1001233.s006 (1.55 MB TIF)
Table S1 Splice site analysis of polymorphisms in the ASVD risk
interval near ANRIL exon-intron boundaries. SNPs within 200 bp
of an ANRIL inton-exon boundary were analyzed for their effects
on putative exon splicing enhancer (ESE), exon splicing silencer
(ESS), intron splicing enhancer (ISE), and intron splicing silencer
(ISS) sequences as described ([54,55] and Z. Wang unpublished
data). A score of -1 indicates that the minor allele destroys one cis-
element and +1 indicates that the minor allele creates one cis-
element. SNPs identified as unique to the AA or GG samples using
sequence capture are shown in blue. Those identified in the
HapMap database are depicted in black. The position of each
intronic SNP relative to the nearest ANRIL exon is given under the
‘ANRIL Position’ column. Exonic SNPs in this column, list the
exon in which they occur. If available, the minor allele frequency
from Utah residents with ancestry from northern and western
Europe (HapMap3, CEU) is given in the ‘CEU Minor Allele’
column. H- Hapmap3; GG- individuals homozygous for the ‘G’
allele at rs10757278.
Found at: doi:10.1371/journal.pgen.1001233.s007 (0.59 MB TIF)
Table S2 Primers used for RACE, Taqman, and PCR analysis.
Found at: doi:10.1371/journal.pgen.1001233.s008 (0.67 MB TIF)
Acknowlegments
We would like to thank Drs. D. Chiang, X. Guan, H. Kelkar, and P.
Mieczkowski for their advice and support in analyzing RNA-sequencing
and sequence capture data. We would also like to thank Drs. S. Hammond
and C. Welch for comments on the MS. We appreciate help from Drs. N.
Mitin and J. Yeh in providing reagents for these studies.
Author Contributions
Conceived and designed the experiments: CEB WRJ ZW NES. Performed
the experiments: CEB WRJ YL. Analyzed the data: CEB WRJ YL ZW
NES. Contributed reagents/materials/analysis tools: HKS ZW. Wrote the
paper: CEB WRJ NES.
References
1. World Health Organization W (2009) Cardiovascular diseases Fact Sheet.
2. Biros E, Cooper M, Palmer LJ, Walker PJ, Norman PE, et al. (2010) Association
of an allele on chromosome 9 and abdominal aortic aneurysm. Atherosclerosis.
3. Bown MJ, Braund PS, Thompson J, London NJ, Samani NJ, et al. (2008)
Association between the coronary artery disease risk locus on chromosome
9p21.3 and abdominal aortic aneurysm. Circ Cardiovasc Genet 1: 39–42.
4. Thompson AR, Golledge J, Cooper JA, Hafez H, Norman PE, et al. (2009)
Sequence variant on 9p21 is associated with the presence of abdominal aortic
aneurysm disease but does not have an impact on aneurysmal expansion.
Eur J Hum Genet 17: 391–394.
5. Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, et al.
(2007) A common variant on chromosome 9p21 affects the risk of myocardial
infarction. Science 316: 1491–1493.
6. Helgadottir A, Thorleifsson G, Magnusson KP, Gretarsdottir S,
Steinthorsdottir V, et al. (2008) The same sequence variant on 9p21 associates
with myocardial infarction, abdominal aortic aneurysm and intracranial
aneurysm. Nat Genet 40: 217–224.
7. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, et al. (2007) A
common allele on chromosome 9 associated with coronary heart disease. Science
316: 1488–1491.
8. Matarin M, Brown WM, Singleton A, Hardy JA, Meschia JF (2008) Whole
genome analyses suggest ischemic stroke and heart disease share an association
with polymorphisms on chromosome 9p21. Stroke 39: 1586–1589.
9. Gschwendtner A, Bevan S, Cole JW, Plourde A, Matarin M, et al. (2009)
Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke.
Ann Neurol 65: 531–539.
10. Smith JG, Melander O, Lovkvist H, Hedblad B, Engstrom G, et al. (2009)
Common genetic variants on chromosome 9p21 confers risk of ischemic stroke:
a large-scale genetic association study. Circ Cardiovasc Genet 2: 159–164.
11. Cluett C, McDermott MM, Guralnik J, Ferrucci L, Bandinelli S, et al. (2009)
The 9p21 myocardial infarction risk allele increases risk of peripheral artery
disease in older people. Circ Cardiovasc Genet 2: 347–353.
12. Ye S, Willeit J, Kronenberg F, Xu Q, Kiechl S (2008) Association of genetic
variation on chromosome 9p21 with susceptibility and progression of
atherosclerosis: a population-based, prospective study. J Am Coll Cardiol 52:
378–384.
13. Broadbent HM, Peden JF, Lorkowski S, Goel A, Ongen H, et al. (2008)
Susceptibility to coronary artery disease and diabetes is encoded by distinct,
tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet
17: 806–814.
cANRIL Expression and Structure
PLoS Genetics | www.plosgenetics.org 13 December 2010 | Volume 6 | Issue 12 | e100123314. Seidelmann SB, Kuo C, Pleskac N, Molina J, Sayers S, et al. (2008) Athsq1 is an
atherosclerosis modifier locus with dramatic effects on lesion area and prominent
accumulation of versican. Arterioscler Thromb Vasc Biol 28: 2180–2186.
15. Kim WY, Sharpless NE (2006) The regulation of INK4/ARF in cancer and
aging. Cell 127: 265–275.
16. Liu Y, Sanoff HK, Cho H, Burd CE, Torrice C, et al. (2009) INK4/ARF
transcript expression is associated with chromosome 9p21 variants linked to
atherosclerosis. PLoS One 4: e5027.
17. Wessely R (2010) Atherosclerosis and cell cycle: put the brakes on! Critical role
for cyclin-dependent kinase inhibitors. J Am Coll Cardiol 55: 2269–2271.
18. Boehm M, Nabel EG (2003) The cell cycle and cardiovascular diseases. Prog
Cell Cycle Res 5: 19–30.
19. Gizard F, Amant C, Barbier O, Bellosta S, Robillard R, et al. (2005) PPAR
alpha inhibits vascular smooth muscle cell proliferation underlying intimal
hyperplasia by inducing the tumor suppressor p16INK4a. J Clin Invest 115:
3228–3238.
20. Gonzalez-Navarro H, Abu Nabah YN, Vinue A, Andres-Manzano MJ,
Collado M, et al. (2010) p19(ARF) deficiency reduces macrophage and vascular
smooth muscle cell apoptosis and aggravates atherosclerosis. J Am Coll Cardiol
55: 2258–2268.
21. Kalinina N, Agrotis A, Antropova Y, Ilyinskaya O, Smirnov V, et al. (2004)
Smad expression in human atherosclerotic lesions: evidence for impaired TGF-
beta/Smad signaling in smooth muscle cells of fibrofatty lesions. Arterioscler
Thromb Vasc Biol 24: 1391–1396.
22. Reynisdottir I, Polyak K, Iavarone A, Massague J (1995) Kip/Cip and Ink4 Cdk
inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes
Dev 9: 1831–1845.
23. Grainger DJ (2004) Transforming growth factor beta and atherosclerosis: so far,
so good for the protective cytokine hypothesis. Arterioscler Thromb Vasc Biol
24: 399–404.
24. Janzen V, Forkert R, Fleming HE, Saito Y, Waring MT, et al. (2006) Stem-cell
ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature
443: 421–426.
25. Yvan-Charvet L, Pagler T, Gautier EL, Avagyan S, Siry RL, et al. (2010) ATP-
binding cassette transporters and HDL suppress hematopoietic stem cell
proliferation. Science 328: 1689–1693.
26. Visel A, Zhu Y, May D, Afzal V, Gong E, et al. (2010) Targeted deletion of the
9p21 non-coding coronary artery disease risk interval in mice. Nature 464:
409–412.
27. Pasmant E, Laurendeau I, Heron D, Vidaud M, Vidaud D, et al. (2007)
Characterization of a germ-line deletion, including the entire INK4/ARF locus,
in a melanoma-neural system tumor family: identification of ANRIL, an
antisense noncoding RNA whose expression coclusters with ARF. Cancer Res
67: 3963–3969.
28. Folkersen L, Kyriakou T, Goel A, Peden J, Malarstig A, et al. (2009)
Relationship between CAD risk genotype in the chromosome 9p21 locus and
gene expression. Identification of eight new ANRIL splice variants. PLoS One 4:
e7677.
29. Kyriakou T, Pal A, Peden J, Green F, Gloyn A, et al. (2009) ANRIL, The non-
coding RNA present in the chromosome 9 CAD associated locus, has multiple
splice variants and a potential regulatory role in CDKN2B expression.
Atherosclerosis 207: e3.
30. Jarinova O, Stewart AF, Roberts R, Wells G, Lau P, et al. (2009) Functional
analysis of the chromosome 9p21.3 coronary artery disease risk locus.
Arterioscler Thromb Vasc Biol 29: 1671–1677.
31. Jacobs JJ, Kieboom K, Marino S, DePinho RA, van Lohuizen M (1999) The
oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and
senescence through the ink4a locus. Nature 397: 164–168.
32. Dhawan S, Tschen SI, Bhushan A (2009) Bmi-1 regulates the Ink4a/Arf locus to
control pancreatic beta-cell proliferation. Genes Dev 23: 906–911.
33. Chen H, Gu X, Su IH, Bottino R, Contreras JL, et al. (2009) Polycomb protein
Ezh2 regulates pancreatic beta-cell Ink4a/Arf expression and regeneration in
diabetes mellitus. Genes Dev 23: 975–985.
34. Kotake Y, Cao R, Viatour P, Sage J, Zhang Y, et al. (2007) pRB family proteins
are required for H3K27 trimethylation and Polycomb repression complexes
binding to and silencing p16INK4alpha tumor suppressor gene. Genes Dev 21:
49–54.
35. Bracken AP, Kleine-Kohlbrecher D, Dietrich N, Pasini D, Gargiulo G, et al.
(2007) The Polycomb group proteins bind throughout the INK4A-ARF locus
and are disassociated in senescent cells. Genes Dev 21: 525–530.
36. Gil J, Peters G (2006) Regulation of the INK4b-ARF-INK4a tumour suppressor
locus: all for one or one for all. Nat Rev Mol Cell Biol 7: 667–677.
37. Terranova R, Yokobayashi S, Stadler MB, Otte AP, van Lohuizen M, et al.
(2008) Polycomb group proteins Ezh2 and Rnf2 direct genomic contraction and
imprinted repression in early mouse embryos. Dev Cell 15: 668–679.
38. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, et al. (2007) Functional
demarcation of active and silent chromatin domains in human HOX loci by
noncoding RNAs. Cell 129: 1311–1323.
39. Zhao J, Sun BK, Erwin JA, Song JJ, Lee JT (2008) Polycomb proteins targeted
by a short repeat RNA to the mouse X chromosome. Science 322: 750–756.
40. Pandey RR, Mondal T, Mohammad F, Enroth S, Redrup L, et al. (2008)
Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional
silencing through chromatin-level regulation. Mol Cell 32: 232–246.
41. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, et al. (2010) Long non-
coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature 464: 1071–1076.
42. Liu Y, Sanoff HK, Cho H, Burd CE, Torrice C, et al. (2009) Expression of
p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging
Cell 8: 439–448.
43. Hara E, Smith R, Parry D, Tahara H, Stone S, et al. (1996) Regulation of
p16CDKN2 expression and its implications for cell immortalization and
senescence. Mol Cell Biol 16: 859–867.
44. Krishnamurthy J, Torrice C, Ramsey MR, Kovalev GI, Al-Regaiey K, et al.
(2004) Ink4a/Arf expression is a biomarker of aging. J Clin Invest 114:
1299–1307.
45. Au KF, Jiang H, Lin L, Xing Y, Wong WH (2010) Detection of splice junctions
from paired-end RNA-seq data by SpliceMap. Nucleic Acids Res.
46. Nielsen GP, Stemmer-Rachamimov AO, Shaw J, Roy JE, Koh J, et al. (1999)
Immunohistochemical survey of p16INK4A expression in normal human adult
and infant tissues. Lab Invest 79: 1137–1143.
47. Schmid M, Sen M, Rosenbach MD, Carrera CJ, Friedman H, et al. (2000) A
methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new
gene on chromosome 9p21 that is frequently deleted in cancer. Oncogene 19:
5747–5754.
48. Chen K, Wallis JW, McLellan MD, Larson DE, Kalicki JM, et al. (2009)
BreakDancer: an algorithm for high-resolution mapping of genomic structural
variation. Nat Methods 6: 677–681.
49. Zaphiropoulos PG (1996) Circular RNAs from transcripts of the rat cytochrome
P450 2C24 gene: correlation with exon skipping. Proc Natl Acad Sci U S A 93:
6536–6541.
50. Suzuki H, Zuo Y, Wang J, Zhang MQ, Malhotra A, et al. (2006)
Characterization of RNase R-digested cellular RNA source that consists of
lariat and circular RNAs from pre-mRNA splicing. Nucleic Acids Res 34: e63.
51. Dixon RJ, Eperon IC, Hall L, Samani NJ (2005) A genome-wide survey
demonstrates widespread non-linear mRNA in expressed sequences from
multiple species. Nucleic Acids Res 33: 5904–5913.
52. Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-
Wheeler transform. Bioinformatics 25: 1754–1760.
53. Li R, Li Y, Kristiansen K, Wang J (2008) SOAP: short oligonucleotide
alignment program. Bioinformatics 24: 713–714.
54. Wang Z, Rolish ME, Yeo G, Tung V, Mawson M, et al. (2004) Systematic
identification and analysis of exonic splicing silencers. Cell 119: 831–845.
55. Fairbrother WG, Yeh RF, Sharp PA, Burge CB (2002) Predictive identification
of exonic splicing enhancers in human genes. Science 297: 1007–1013.
56. Wang Z, Burge CB (2008) Splicing regulation: from a parts list of regulatory
elements to an integrated splicing code. Rna 14: 802–813.
57. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, et al. (2007) A second
generation human haplotype map of over 3.1 million SNPs. Nature 449:
851–861.
58. Nigro JM, Cho KR, Fearon ER, Kern SE, Ruppert JM, et al. (1991) Scrambled
exons. Cell 64: 607–613.
59. Holdt LM, Beutner F, Scholz M, Gielen S, Gabel G, et al. (2010) ANRIL
expression is associated with atherosclerosis risk at chromosome 9p21.
Arterioscler Thromb Vasc Biol 30: 620–627.
60. Cunnington MS, Santibanez Koref M, Mayosi BM, Burn J, Keavney B (2010)
Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes
Correlate with ANRIL Expression. PLoS Genet 6: e1000899.
61. Messaoudi-Aubert SE, Nicholls J, Maertens GN, Brookes S, Bernstein E, et al.
(2010) Role for the MOV10 RNA helicase in polycomb-mediated repression of
the INK4a tumor suppressor. Nat Struct Mol Biol 17: 862–868.
62. Yap KL, Li S, Munoz-Cabello AM, Raguz S, Zeng L, et al. (2010) Molecular
interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27
by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell 38:
662–674.
63. Mancini-Dinardo D, Steele SJ, Levorse JM, Ingram RS, Tilghman SM (2006)
Elongation of the Kcnq1ot1 transcript is required for genomic imprinting of
neighboring genes. Genes Dev 20: 1268–1282.
64. Kanduri C, Thakur N, Pandey RR (2006) The length of the transcript encoded
from the Kcnq1ot1 antisense promoter determines the degree of silencing.
Embo J 25: 2096–2106.
65. Dixon RJ, Eperon IC, Samani NJ (2007) Complementary intron sequence motifs
associated with human exon repetition: a role for intragenic, inter-transcript
interactions in gene expression. Bioinformatics 23: 150–155.
66. Cocquerelle C, Daubersies P, Majerus MA, Kerckaert JP, Bailleul B (1992)
Splicing with inverted order of exons occurs proximal to large introns. Embo J
11: 1095–1098.
67. Bonen L, Vogel J (2001) The ins and outs of group II introns. Trends Genet 17:
322–331.
68. Kos A, Dijkema R, Arnberg AC, van der Meide PH, Schellekens H (1986) The
hepatitis delta (delta) virus possesses a circular RNA. Nature 323: 558–560.
69. Tsagris EM, Martinez de Alba AE, Gozmanova M, Kalantidis K (2008) Viroids.
Cell Microbiol 10: 2168–2179.
70. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, et al. (2007)
Replication of genome-wide association signals in UK samples reveals risk loci
for type 2 diabetes. Science 316: 1336–1341.
cANRIL Expression and Structure
PLoS Genetics | www.plosgenetics.org 14 December 2010 | Volume 6 | Issue 12 | e100123371. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, et al. (2007) A genome-
wide association study of type 2 diabetes in Finns detects multiple susceptibility
variants. Science 316: 1341–1345.
72. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, et al. (2009)
Genome-wide association study identifies five susceptibility loci for glioma. Nat
Genet 41: 899–904.
73. Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, et al. (2009) Variants in
the CDKN2B and RTEL1 regions are associated with high-grade glioma
susceptibility. Nat Genet 41: 905–908.
74. Uno S, Zembutsu H, Hirasawa A, Takahashi A, Kubo M, et al. (2010) A
genome-wide association study identifies genetic variants in the CDKN2BAS
locus associated with endometriosis in Japanese. Nat Genet 42: 707–710.
75. Bei JX, Li Y, Jia WH, Feng BJ, Zhou G, et al. (2010) A genome-wide association
study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat
Genet 42: 599–603.
76. Emanuele E, Fontana JM, Minoretti P, Geroldi D (2010) Preliminary evidence
of a genetic association between chromosome 9p21.3 and human longevity.
Rejuvenation Res 13: 23–26.
77. Sebastiani P, Solovieff N, Puca A, Hartley SW, Melista E, et al. (2010) Genetic
Signatures of Exceptional Longevity in Humans. Science.
78. Hanker AB, Morita S, Repasky GA, Ross DT, Seitz RS, et al. (2008) Tools to
study the function of the Ras-related, estrogen-regulated growth inhibitor in
breast cancer. Methods Enzymol 439: 53–72.
79. Brookes S, Rowe J, Ruas M, Llanos S, Clark PA, et al. (2002) INK4a-deficient
human diploid fibroblasts are resistant to RAS-induced senescence. Embo J 21:
2936–2945.
80. Shields JM, Thomas NE, Cregger M, Berger AJ, Leslie M, et al. (2007) Lack of
extracellular signal-regulated kinase mitogen-activated protein kinase signaling
shows a new type of melanoma. Cancer Res 67: 1502–1512.
81. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, et al. (2009) The Sequence
Alignment/Map format and SAMtools. Bioinformatics 25: 2078–2079.
cANRIL Expression and Structure
PLoS Genetics | www.plosgenetics.org 15 December 2010 | Volume 6 | Issue 12 | e1001233